How COVID Boosted Medtech In The Eyes Of The World
Pandemic Is A Reminder That 'It Takes A Village' For Patients To Be Treated
Executive Summary
Reaching deep and being resourceful were the in-demand attributes that medtech industry leaders brought to bear when the COVID-19 pandemic stretched health care providers almost to breaking point.
You may also be interested in...
Medtech 100: For Edwards Lifesciences' Mike Mussallem, Inspiring People Has Been A Way Of Life
Edwards Lifesciences CEO Mike Mussallem has a unique and long-standing perspective of what the medtech industry should be and do. In over two decades, he has built the structural heart disease and critical care monitoring company into one of the global medtech industry’s most effective innovators. That legacy is sure to last after his retirement as CEO in spring 2023.
Making The Most Of A Renaissance Moment In Health Care
The rise of digital alongside long-established physical methods of care delivery should not give rise to notions of an "either/or" choice, but should rather be seen as an “and,” said Accenture’s Andrew Meade in conversation with In Vivo.
The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’
The journey to Net Zero, described as ‘the defining issue of our time,’ will get harder in the coming decade. Failure to keep up the pressure will result in more long-term health conditions, increasing deaths and higher costs. The UK NHS is a Net Zero exemplar globally, but without a systemic approach, its compliance efforts could stutter.